In this chapter, we summarize the relationship between circulating high-density lipoprotein (HDL) and atherosclerotic cardiovascular disease (ASCVD). HDL acts in many types of cells, such as endothelial cell, macrophage, T lymphocyte, etc. Recently, novel HDL-related therapies have been developed to treat ASCVD. © 2022. Springer Nature Singapore Pte Ltd.
Hongtu Cui, Qian Du. HDL and ASCVD. Advances in experimental medicine and biology. 2022;1377:109-118
PMID: 35575924
View Full Text